{
  "cik": 1601830,
  "cik_padded": "0001601830",
  "entityName": "RECURSION PHARMACEUTICALS, INC.",
  "fiscal_years": [
    {
      "accn": "0001601830-26-000039",
      "filed": "2026-02-25",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 6469000.0,
        "cash": 743294000.0,
        "eps_diluted": -1.44,
        "free_cash_flow": -378277000.0,
        "net_income": -644759000.0,
        "operating_cash_flow": -371808000.0,
        "operating_income": -648132000.0,
        "revenue": 74681000.0,
        "stockholders_equity": 1130865000.0,
        "total_assets": 1474130000.0,
        "total_liabilities": 343265000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.303541978927635,
        "revenue_growth_yoy": 0.26924318904128214,
        "roa_avg2y": -0.4412035605092229,
        "roa_period_end": -0.4373827274392353,
        "roe_avg2y": -0.595442378189982,
        "roe_period_end": -0.5701467460749072
      }
    },
    {
      "accn": "0001601830-26-000039",
      "filed": "2026-02-25",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 13695000.0,
        "cash": 594350000.0,
        "eps_diluted": -1.69,
        "free_cash_flow": -372869000.0,
        "net_income": -463661000.0,
        "operating_cash_flow": -359174000.0,
        "operating_income": -479004000.0,
        "revenue": 58839000.0,
        "stockholders_equity": 1034782000.0,
        "total_assets": 1448598000.0,
        "total_liabilities": 413816000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.39990645372648537,
        "revenue_growth_yoy": 0.32,
        "roa_avg2y": -0.44109942600878943,
        "roa_period_end": -0.3200756869745781,
        "roe_avg2y": -0.6189499792420061,
        "roe_period_end": -0.44807601987665036
      }
    },
    {
      "accn": "0001601830-26-000039",
      "filed": "2026-02-25",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 11955000.0,
        "cash": 391565000.0,
        "eps_diluted": -1.58,
        "free_cash_flow": -299735000.0,
        "net_income": -328066000.0,
        "operating_cash_flow": -287780000.0,
        "operating_income": -350060000.0,
        "revenue": 44575000.0,
        "stockholders_equity": 463436000.0,
        "total_assets": 653699000.0,
        "total_liabilities": 190263000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4105485978646458,
        "revenue_growth_yoy": 0.11876615716688001,
        "roa_avg2y": -0.4842349040987109,
        "roa_period_end": -0.501860948234585,
        "roe_avg2y": -0.6912167813897826,
        "roe_period_end": -0.7078992568553155
      }
    },
    {
      "accn": "0001601830-26-000039",
      "filed": "2026-02-25",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 37059000.0,
        "cash": 549912000.0,
        "eps_diluted": -1.36,
        "free_cash_flow": -120583000.0,
        "net_income": -239476000.0,
        "operating_cash_flow": -83524000.0,
        "operating_income": -245727000.0,
        "revenue": 39843000.0,
        "stockholders_equity": 485806000.0,
        "total_assets": 701288000.0,
        "total_liabilities": 215482000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.443555658019868,
        "revenue_growth_yoy": 2.9146197681273334,
        "roa_avg2y": -0.36515702181936566,
        "roa_period_end": -0.34148024777266967,
        "roe_avg2y": -0.4655696655338938,
        "roe_period_end": -0.4929457437742638
      }
    },
    {
      "accn": "0001601830-25-000035",
      "filed": "2025-02-28",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 39798000.0,
        "cash": 285116000.0,
        "eps_diluted": -1.49,
        "free_cash_flow": -198412000.0,
        "net_income": -186479000.0,
        "operating_cash_flow": -158614000.0,
        "operating_income": -182775000.0,
        "revenue": 10178000.0,
        "stockholders_equity": 542938000.0,
        "total_assets": 610345000.0,
        "total_liabilities": 67407000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1241522973157156,
        "revenue_growth_yoy": 1.568904593639576,
        "roa_avg2y": -0.41032642777771666,
        "roa_period_end": -0.3055304786637066,
        "roe_avg2y": -1.10785417452599,
        "roe_period_end": -0.343462789489776
      }
    },
    {
      "accn": "0001601830-24-000019",
      "filed": "2024-02-29",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5831000.0,
        "cash": 262126000.0,
        "eps_diluted": -3.99,
        "free_cash_flow": -51230000.0,
        "net_income": -87006000.0,
        "operating_cash_flow": -45399000.0,
        "operating_income": -84615000.0,
        "revenue": 3962000.0,
        "stockholders_equity": -206289000.0,
        "total_assets": 298585000.0,
        "total_liabilities": 56562000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": 0.7084950409659336,
        "roa_period_end": -0.2913944103019241,
        "roe_avg2y": 0.5264253344385487
      }
    },
    {
      "accn": "0001601830-23-000010",
      "filed": "2023-02-27",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "capex": 3910000.0,
        "eps_diluted": -2.87,
        "free_cash_flow": -60952000.0,
        "net_income": -61879000.0,
        "operating_cash_flow": -57042000.0,
        "operating_income": -62441000.0,
        "revenue": 2319000.0,
        "stockholders_equity": -124265000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": 0.6578952964191546
      }
    },
    {
      "accn": "0001601830-22-000012",
      "filed": "2022-03-23",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -63847000.0
      },
      "period_end": "2018-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001601830-26-000039",
    "filed": "2026-02-25",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001601830.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001601830.json"
  },
  "ticker": "RXRX"
}